Literature DB >> 8619616

Calcium dependent association of surfactant protein A with pulmonary surfactant: application to simple surfactant protein A purification.

A Suwabe1, R J Mason, D R Voelker.   

Abstract

Surfactant protein A (SP-A) is an abundant lipoprotein component of pulmonary surfactant that plays multiple roles in surfactant homeostasis within the lung. A simple and rapid purification procedure for SP-A is described. Purified surfactant is washed by centrifugation with Ca2+ containing buffer to remove residual soluble proteins. Following the Ca2+ buffer wash, the surfactant pellet is washed in buffer containing EGTA and Mg2+ which releases the bound SP-A in almost pure form. Subsequent chromatography of the SP-A on Sephacryl S-500 yields homogeneous preparations of the protein. The SP-A purified using this procedure requires no exposure to either detergents or organic solvents to remove lipid. SP-A prepared by this new method inhibits lipid secretion from alveolar type II cells as effectively as SP-A prepared by other methods. In addition, the SP-A depleted surfactant produced in the first step of this procedure is capable of binding exogenous SP-A in a time dependent, saturable and Ca2+ dependent manner.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8619616     DOI: 10.1006/abbi.1996.0123

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  15 in total

1.  Surfactant protein A is defective in abrogating inflammation in asthma.

Authors:  Ying Wang; Dennis R Voelker; Njira L Lugogo; Guirong Wang; Joanna Floros; Jennifer L Ingram; Hong Wei Chu; Tony D Church; Pitchaimani Kandasamy; Daniel Fertel; Jo Rae Wright; Monica Kraft
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-22       Impact factor: 5.464

2.  Identification and Quantitation of Coding Variants and Isoforms of Pulmonary Surfactant Protein A.

Authors:  Matthew W Foster; J Will Thompson; Julie G Ledford; Laura G Dubois; John W Hollingsworth; Dave Francisco; Sasipa Tanyaratsrisakul; Dennis R Voelker; Monica Kraft; M Arthur Moseley; W Michael Foster
Journal:  J Proteome Res       Date:  2014-07-15       Impact factor: 4.466

3.  Surface-bound myeloperoxidase is a ligand for recognition of late apoptotic neutrophils by human lung surfactant proteins A and D.

Authors:  Anne Jäkel; Howard Clark; Kenneth B M Reid; Robert B Sim
Journal:  Protein Cell       Date:  2010-07-07       Impact factor: 14.870

4.  The Pseudomonas aeruginosa flagellum confers resistance to pulmonary surfactant protein-A by impacting the production of exoproteases through quorum-sensing.

Authors:  Zhizhou Kuang; Yonghua Hao; Sunghei Hwang; Shiping Zhang; Eunice Kim; Henry T Akinbi; Michael J Schurr; Randall T Irvin; Daniel J Hassett; Gee W Lau
Journal:  Mol Microbiol       Date:  2011-01-06       Impact factor: 3.501

5.  Surfactant protein A (SP-A) binds to phosphatidylserine and competes with annexin V binding on late apoptotic cells.

Authors:  Anne Jäkel; Kenneth B M Reid; Howard Clark
Journal:  Protein Cell       Date:  2010-02-06       Impact factor: 14.870

6.  Interaction of surfactant protein A with lipopolysaccharide and regulation of inflammatory cytokines in the THP-1 monocytic cell line.

Authors:  M Song; D S Phelps
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

7.  Type IV pilus glycosylation mediates resistance of Pseudomonas aeruginosa to opsonic activities of the pulmonary surfactant protein A.

Authors:  Rommel M Tan; Zhizhou Kuang; Yonghua Hao; Francis Lee; Timothy Lee; Ryan J Lee; Gee W Lau
Journal:  Infect Immun       Date:  2015-01-20       Impact factor: 3.441

8.  Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants.

Authors:  Anatoly N Mikerov; Todd M Umstead; Xiaozhuang Gan; Weixiong Huang; Xiaoxuan Guo; Guirong Wang; David S Phelps; Joanna Floros
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-02       Impact factor: 5.464

9.  Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability.

Authors:  Huixing Wu; Alexander Kuzmenko; Sijue Wan; Lyndsay Schaffer; Alison Weiss; James H Fisher; Kwang Sik Kim; Francis X McCormack
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

10.  Type IV pilus of Pseudomonas aeruginosa confers resistance to antimicrobial activities of the pulmonary surfactant protein-A.

Authors:  Rommel Max Tan; Zhizhou Kuang; Yonghua Hao; Gee W Lau
Journal:  J Innate Immun       Date:  2013-09-25       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.